1st Quarter - Report

NATIONAL ASSOCIATION OF CHAIN DRUG STORES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES

Firm
Client
Income
—
Expenses
$490,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 501 Block, Report, And Suspend Suspicious Shipments Act H.R. 895 Combating Organized Retail Crime Act H.R. 1613 Drug Price Transparency in Medicaid Act 2023 H.R. 1770 The Equitable Community Access to Pharmacist Services Act S. 113 Prescription Pricing for the People Act S. 127 Pharmacy Benefit Manager Transparency Act S. 140 Combating Organized Retail Crime Act

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: S. 113 (118th), H.R. 501 (118th), H.R. 895 (118th), H.R. 1613 (118th), S. 140 (118th), S. 127 (118th), H.R. 1770 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.